Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lohith Gowda

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Blood|April 18, 2024
Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicityFrederick L Locke, Tanya Siddiqi, Caron A Jacobson, et al.
Transplantation and Cellular Therapy|June 27, 2026
Infections within 100 days of idecabtagene vicleucel and impact on survival for relapsed/refractory multiple myeloma: A CIBMTR AnalysisKitsada Wudhikarn, Lohith Gowda, Qiran Ye, et al.
Transplantation and Cellular Therapy|June 24, 2026
Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell LymphomaNausheen Ahmed, Alaa Ali, Soyoung Kim, et al.
Blood Advances|May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTRKitsada Wudhikarn, Megan M Herr, Min Chen, et al.
Blood Advances|February 24, 2023
Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysisBrittany Knick Ragon, Mithun Vinod Shah, Anita D'Souza, et al.
Blood Neoplasia|March 23, 2026
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomasAbu-Sayeef Mirza, Chitra Hosing, Francine Foss, et al.
Leukemia|October 31, 2022
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patientsMichael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Leukemia|March 23, 2023
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patientsMichael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Blood Advances|September 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AMLKamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, et al.
Transplantation and Cellular Therapy|January 26, 2022
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant ResearchHemant S Murthy, Kwang Woo Ahn, Noel Estrada-Merly, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Blood|April 18, 2024
Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicityFrederick L Locke, Tanya Siddiqi, Caron A Jacobson, et al.
Transplantation and Cellular Therapy|June 27, 2026
Infections within 100 days of idecabtagene vicleucel and impact on survival for relapsed/refractory multiple myeloma: A CIBMTR AnalysisKitsada Wudhikarn, Lohith Gowda, Qiran Ye, et al.
Transplantation and Cellular Therapy|June 24, 2026
Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell LymphomaNausheen Ahmed, Alaa Ali, Soyoung Kim, et al.
Blood Advances|May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTRKitsada Wudhikarn, Megan M Herr, Min Chen, et al.
Blood Advances|February 24, 2023
Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysisBrittany Knick Ragon, Mithun Vinod Shah, Anita D'Souza, et al.
Blood Neoplasia|March 23, 2026
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomasAbu-Sayeef Mirza, Chitra Hosing, Francine Foss, et al.
Leukemia|October 31, 2022
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patientsMichael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Leukemia|March 23, 2023
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patientsMichael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Blood Advances|September 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AMLKamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, et al.
Transplantation and Cellular Therapy|January 26, 2022
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant ResearchHemant S Murthy, Kwang Woo Ahn, Noel Estrada-Merly, et al.
Pageof 6